Published in Medical Verdicts and Law Weekly, December 14th, 2006
This trend article about Pfizer, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: New investigation results, "Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers," are detailed in a study published in Journal of Clinical Pharmacology. According to recent research from the United States, "Varenicline is a novel selective alpha4beta2 nicotinic acetylcholine partial agonist developed for smoking cessation. This study investigated the single-and multiple-dose pharmacokinetics, safety, and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.